Cooling Device for Chemotherapy-Induced Peripheral NeuropathyTechnology #12294n
Questions about this technology? Ask a Technology Manager
The global neuropathic pain market was valued at US$ 5.4 Bn in 2016. The market is projected to expand at a CAGR of 5.6% during an eight-year forecast period 2016–2024 and reach US$ 8.3 Bn by the end of 2024 and the Chemotherapy Induced Peripheral Neuropathy segment is estimated to account for 42.4% revenue share in the global neuropathic pain market by 2016 end.
A novel cooling device to the arms and legs has been developed to prevent complications of chemotherapy to the peripheral nervous system. The designed cooling device can reduce nerve exposure to chemotherapy and has biofeedback mechanisms to the limbs including the monitoring of the blood -flow and temperature. Successful pilot studies have been conducted with healthy and cancer subjects.
STAGE OF DEVELOPMENT
In the hospitals, clinics and medical facilities providing
chemotherapy for cancer treatment and care.
Only specific technology to prevent and reverse
chemotherapy-induced peripheral neuropathy.
Improves patients’ quality of life while undergoing
Patent pending. Available for licensing.
Technology Manager: Dr Ler Ser Yeng Phone: +65- 6601 6248
E-mail: firstname.lastname@example.org ILO Ref No: 12294N
Inventor: Prof Einar P.V. Wilder-Smith E-mail: email@example.com